Add as a preferred source on GoogleTransMedics Shares Post Biggest Intraday Gain Since November 2023
The stock rose more than 25% on Nov. 6 after third-quarter results and an increase to the company’s 2026 revenue outlook.
TransMedics Group, Inc. shares rose more than 25% Friday, Nov. 6, marking the stock’s strongest intraday gain since November 2023. The rally followed the company’s third-quarter results and an increase to its 2026 revenue outlook.
TransMedics’ 2026 revenue forecast is $764 million to $774 million, including about $14 million from PAD Aviation. Excluding PAD Aviation, the range is $750 million to $760 million, up from $737 million to $757 million previously. The company’s updated revenue guidance includes the full breakdown.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.